Intellia Therapeutics Inc (NTLA)
31.60
-0.16
(-0.50%)
USD |
NASDAQ |
Sep 29, 16:00
31.83
+0.23
(+0.73%)
After-Hours: 20:00
Intellia Therapeutics Price: 31.60 for Sept. 29, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2023 | 32.22 | 32.47 | 31.39 | 31.60 | 600498.0 |
| Sep 28, 2023 | 32.00 | 32.34 | 31.13 | 31.76 | 773180.0 |
| Sep 27, 2023 | 32.49 | 32.91 | 31.50 | 32.09 | 913138.0 |
| Sep 26, 2023 | 32.19 | 33.37 | 32.16 | 32.35 | 710161.0 |
| Sep 25, 2023 | 32.13 | 32.77 | 31.66 | 32.21 | 778087.0 |
| Sep 22, 2023 | 33.80 | 34.04 | 32.37 | 32.39 | 823739.0 |
| Sep 21, 2023 | 33.34 | 33.80 | 32.64 | 33.53 | 985459.0 |
| Sep 20, 2023 | 34.68 | 34.94 | 33.88 | 33.99 | 801899.0 |
| Sep 19, 2023 | 34.87 | 34.90 | 33.82 | 34.37 | 893627.0 |
| Sep 18, 2023 | 35.65 | 35.88 | 34.96 | 35.02 | 844018.0 |
| Sep 15, 2023 | 36.06 | 36.17 | 35.54 | 35.82 | 1.691M |
| Sep 14, 2023 | 35.80 | 36.25 | 35.58 | 36.01 | 763608.0 |
| Sep 13, 2023 | 37.06 | 37.16 | 35.36 | 35.50 | 1.338M |
| Sep 12, 2023 | 38.25 | 38.71 | 37.11 | 37.15 | 681659.0 |
| Sep 11, 2023 | 38.03 | 38.35 | 37.53 | 38.25 | 629739.0 |
| Sep 08, 2023 | 37.87 | 37.98 | 37.02 | 37.87 | 480530.0 |
| Sep 07, 2023 | 37.47 | 38.10 | 36.67 | 37.69 | 547215.0 |
| Sep 06, 2023 | 37.99 | 38.69 | 37.65 | 38.19 | 469167.0 |
| Sep 05, 2023 | 37.30 | 38.30 | 36.90 | 37.97 | 887447.0 |
| Sep 01, 2023 | 37.99 | 38.49 | 37.56 | 37.69 | 632526.0 |
| Aug 31, 2023 | 38.07 | 38.24 | 37.32 | 37.48 | 655660.0 |
| Aug 30, 2023 | 38.08 | 38.14 | 37.33 | 37.96 | 570890.0 |
| Aug 29, 2023 | 38.00 | 38.72 | 37.52 | 38.19 | 847812.0 |
| Aug 28, 2023 | 38.61 | 38.79 | 37.75 | 38.01 | 442160.0 |
| Aug 25, 2023 | 37.72 | 38.70 | 37.35 | 38.25 | 599469.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
9.44
Minimum
Mar 16 2020
176.78
Maximum
Sep 03 2021
47.70
Average
38.19
Median
Aug 29 2023
Price Benchmarks
| Pacific Biosciences of California Inc | 8.35 |
| Perspective Therapeutics Inc | 0.2737 |
| Electromed Inc | 10.39 |
| Xtant Medical Holdings Inc | 1.10 |
| Navidea Biopharmaceuticals Inc | 0.0897 |
Price Related Metrics
| PS Ratio | 49.64 |
| PEG Ratio | -2.815 |
| Price to Book Value | 2.531 |
| Earnings Yield | -17.28% |
| Market Cap | 2.796B |
| PEGY Ratio | -2.815 |